Sources | Names Used |
---|---|
GDSC1000 | KIN001-102 |
PharmacoGx | KIN001-102 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ANKRD17 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0006 |
mRNA | NXF1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |
mRNA | B4GALT5 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0006 |
mRNA | CCDC97 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |
mRNA | ARL2BP | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0006 |
mRNA | ZNF200 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |
mRNA | HELZ | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |
mRNA | EXO5 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0006 |
mRNA | FANCF | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |
mRNA | KLHDC10 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0006 |